Mike A. Marks - 29 Jan 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship
EVP and CFO
Issuer ticker
HCA
Reported as of
29 Jan 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Feb 2026, 18:49:34 UTC
Prior SEC filing
05 Nov 2025
Next SEC filing
12 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin A. Ball, Attorney-in-Fact

Key filing fact

Mike A. Marks filed Form 4 for HCA Healthcare, Inc. (HCA) on 02 Feb 2026.

Key facts

  • This page summarizes Mike A. Marks's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 02 Feb 2026, 18:49.

Change

  • Previous filing in this sequence was filed on 05 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001961124 Primary reporting owner

Marks Mike A

Relationship
EVP and CFO
Address
ONE PARK PLAZA, NASHVILLE
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Signature date
02 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCA transaction Derivative

Stock Appreciation Right

Award

Transaction value
$0
Shares
+11,945
Change %
Price
$0.000000
Shares after
11,945
Date
29 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,945
Exercise price
$482.53
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .